A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
De-Escalation Therapy for Human Papillomavirus Negative Disease
- Status
- COMPLETED
- Phase
- PHASE2
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
- Status
- UNKNOWN
- Phase
- N/A
Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)
- Status
- TERMINATED
- Phase
- PHASE2
Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Prognostic Value of Tumor Thickness of Buccal Mucosa Squamous Cell Carcinoma on the Incidence of Nodal Metastasis.
- Status
- UNKNOWN
- Phase
- N/A
Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Rigosertib for RDEB-SCC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cetuximab in Head and Neck Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study Assessing the Safety and Performance of Smart Matrix®
- Status
- UNKNOWN
- Phase
- NA
TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of TVEC in Patients With Cutaneous Squamous Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck
- Status
- RECRUITING
- Phase
- PHASE2
Afatinib and Nivolumab as Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- WITHDRAWN
- Phase
- PHASE1
M6620 Plus Standard Treatment in Oesophageal and Other Cancer
- Status
- COMPLETED
- Phase
- PHASE1